GlassScriptPhysician profile
Benjamin M Milam
NPI 1407145220
$727.04
in general payments reported to CMS, 2019-2025
9 companies · $173 in 2025
The $173 reported for 2025 was less than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $97.48 · 2020: $48.26 · 2022: $67.49 · 2023: $218 · 2024: $124 · 2025: $173.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $514.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $513.81 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Genzyme Corporation | $261.76 | 2022-2025 | |
| Medtronic, INC. | $141.76 | 2023-2025 | Propel |
| E.R. Squibb & Sons, L.L.C. | $97.48 | 2019 | |
| Regeneron Healthcare Solutions, INC. | $75.73 | 2023-2024 | Dupixent |
| Stryker Corporation | $48.32 | 2020-2022 | |
| Cochlear Americas | $40.07 | 2025 | Cochlear Nucleus Ci632 Cochlear Implant With Slim Modiolar Electrode, Osia Osi300 Implant, Baha |
| Inspire Medical Systems, INC. | $24.56 | 2023 | Inspire |
| Optinose US, INC. | $22.38 | 2024 | |
| Olympus America INC. | $14.98 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Benjamin Milam listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.